BRIEF-Quince Marks Final Patient Visit in NEAT Phase 3 Study

Reuters
Dec 15, 2025
BRIEF-Quince Marks Final Patient Visit in NEAT Phase 3 Study

Dec 15 (Reuters) - Quince Therapeutics Inc QNCX.O:

  • QUINCE THERAPEUTICS ANNOUNCES LAST PATIENT LAST VISIT IN PHASE 3 NEAT CLINICAL TRIAL IN PATIENTS WITH ATAXIA-TELANGIECTASIA

  • QUINCE THERAPEUTICS - EXPECTS TOPLINE RESULTS IN Q1 2026

Source text: ID:nBw3kRP1Da

Further company coverage: QNCX.O

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10